Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
08/2004
08/25/2004EP1353750B1 Stable free nitroxyl radicals as oxidation catalysts and process for oxidation
08/25/2004EP1244663B1 Compounds and methods for the treatment of pain
08/25/2004EP0883616B1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
08/25/2004EP0854869B1 Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation
08/25/2004CN1523987A Immune response modifiers for the treatment of periodontal disease
08/25/2004CN1163495C Pyridine compounds, preparation method thereof and pharmaceutical compositions containing them
08/25/2004CN1163363C Optical recording media
08/25/2004CN1163224C Drugs for improving vesical excretory capacity
08/24/2004US6781001 Extended rhodamine dye compound suitable for the creating of sets of spactrally resolvable fluorescent labels particlularly useful for fluorescence based dna sequencing system
08/24/2004US6780992 Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
08/24/2004US6780875 Quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists
08/24/2004US6780874 Autoimmune disease; antiinflammatory agents; antiproliferative agent
08/24/2004US6780873 Urea substituted imidazoquinolines
08/24/2004US6780872 Asthma; antiepileptic agents; sexual disorders
08/24/2004US6780868 Treatment of myocardial or peripheral ischaemia, cardiac insufficiency or pulmonary arterial hypertension
08/24/2004US6780862 Such as amino-indazoles for treatment of central nervous system disorders
08/24/2004US6780857 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
08/24/2004US6780400 Delivery of antiemetics through an inhalation route
08/24/2004US6780399 Delivery of stimulants through an inhalation route
08/19/2004WO2004069835A1 Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists
08/19/2004WO2004069834A1 Tricyclic compound, process for producing the same, and use
08/19/2004WO2004069833A1 Fused-ring pyridine derivative, process for producing the same, and use
08/19/2004WO2004069832A2 Antibacterial agents
08/19/2004WO2004069826A1 Malonamide derivatives as gamma-secretase inhibitors
08/19/2004WO2004069782A2 2-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them
08/19/2004WO2004069394A2 Synthetic method for direct arylation of heterocyclic arenes
08/19/2004WO2004069162A2 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
08/19/2004WO2004058755A3 Compound libraries of imidazo[1,5-a]pyridin-3-yl derivatives and related heterobicycles for targetting compounds capable of binding to g-protein coupled receptors
08/19/2004WO2004058720A3 Compound libraries of 1,3,5-substitute indazole derivatives as compounds for targetting compounds capable of binding to the g-protein coupled receptor
08/19/2004WO2004024076A9 Novel compositions and methods for the treatment of immune related diseases
08/19/2004WO2004009036A3 Compounds compositions and methods
08/19/2004WO2003049702A8 Vanilloid receptor ligands and their use in treatments
08/19/2004US20040162321 For therapy of disease characterized by inflammatory, allergic, or proliferative processes
08/19/2004US20040162310 Tetrahydropyridoethers
08/19/2004US20040162291 For therapy of cardiovascular disorders and erectile dysfunction
08/19/2004US20040162287 Substituted cyclohexane-1,4-diamine compounds
08/19/2004US20040162285 Anti-infective agents
08/19/2004US20040162279 Tricyclic tetrahydroquinoline antibacterial agents
08/19/2004US20040161385 Delivery of beta-blockers through an inhalation route
08/19/2004CA2515311A1 Antibacterial agents
08/19/2004CA2513684A1 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
08/18/2004EP1447402A1 Quinoline compound
08/18/2004EP1446385A1 Preparation and use of substituted imidazoles
08/18/2004EP1311487A4 Derivatives of 1,2-dihydro-7-hydroxyquinolines containing fused rings
08/18/2004EP1268429B1 Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same
08/18/2004EP0876345B1 Heterocyclic compounds as h+-atpases
08/18/2004EP0619813B1 Linked cyclic polyamines with activity against hiv
08/18/2004CN1522256A Novel substituted tetracyclic imidazole derivatives, processes for their preparation, pharamaceutical compositions comprising them and their use as a medicine
08/18/2004CN1522254A Immunomodulating compounds
08/18/2004CN1522245A Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obestity and type II diabetes
08/18/2004CN1162430C High-tension condensed ring nicotine analogue, preparation process and use thereof
08/18/2004CN1162429C Tricyclic vasopressin agonists
08/18/2004CN1162427C Amine derivatives compounds as medicament and its salts and esters used for medicine
08/18/2004CN1162405C Substd. benzoyl ketones, methods for producing them and their use as herbicides
08/18/2004CN1162403C Substituted amino benzonitrile
08/17/2004US6777426 Imidazole and imidazoline derivatives and uses thereof
08/17/2004US6777421 Treating a condition selected from the group consisting of anxiety, depression, substance abuse, neuropathic pain, acute pain, migraine, asthma, cough and improved cognition, in a subject in need thereof comprising administering a compound
08/17/2004US6777420 Heterocyclic antibacterial compounds
08/17/2004US6777414 Nitrogen-containing heterocyclic compounds and benamide compounds and drugs containing the same
08/17/2004US6777406 Substituted pyrroloquinolines and pyridoquinolines as serotinin agonists and antagonists
08/17/2004US6776994 Synergistic mixtures
08/17/2004US6776978 Aerosol comprises particles comprising at least 10 percent by weight of an opioid, and wherein the opioid is not heroin; opiods include morphine, codeine, naltrexone, buprenorphine, fentanyl, nalbuphine, naloxone, etc.
08/12/2004WO2004067703A2 5ht7 antagonists and inverse agonists
08/12/2004WO2004067675A2 Binaphthol based chromophores for the fabrication of blue organic light emitting diodes
08/12/2004WO2004067674A1 Material for organic light-emitting device
08/12/2004WO2004067531A1 Hiv-integrase inhibitors, pharmaceutical compositions, and methods for their use
08/12/2004WO2004067516A1 2,4-diaminopyrimidine derivatives useful as inhibitors of pkc-theta
08/12/2004WO2004067513A1 Antagonists for alpha-2 adrenoceptors
08/12/2004WO2004054504A3 Tricyclic aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2
08/12/2004WO2004046120A3 Diaminotriazoles useful as inhibitors of protein kinases
08/12/2004WO2004046118A3 2-4-(di-phenyl-amino)-pyrimidine derivatives useful for treating hyper-proliferative disorders
08/12/2004WO2004030635A3 Vasculostatic agents and methods of use thereof
08/12/2004WO2002076395A3 Agents and methods for treatment of cancer
08/12/2004US20040158077 Process for preparation of imidazolyl compounds
08/12/2004US20040158076 Tyrosine derivatives
08/12/2004US20040158067 Binding antagonist and arylpyridine for antiinflammatory agents, cardiovascular disorders and antagonist or agonist and for immunology
08/12/2004US20040157908 (-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor
08/12/2004US20040157904 Anilinopyrazole derivatives useful for the treatment of diabetes
08/12/2004US20040157893 Pyrazole compounds useful as protein kinase inhibitors
08/12/2004US20040157879 Urea substituted imidazopyridines
08/12/2004US20040157878 Alzheimer 's disease; parkinson's disease; schizophrenia; antidepressants; anxiolytic agents; brain disorders; psychological disorders
08/12/2004US20040157877 Cycloalkyl-[4-(trifluorophenyl)-oxazol-5yl]-triazolo-pyridines
08/12/2004US20040157875 1, 6-Naphthyridine derivatives and their use to treat diabetes and related disorders
08/12/2004US20040157874 Modifier of immunology response; induce biosynthesis of cytokines; viricides; antitumor agents; anticancer agents
08/12/2004US20040157873 Pyrrolo-indole and pyrrolo-quinoline derivatives as prodrugs for tumour treatment
08/12/2004US20040157870 for treating or preventing attention-deficit disorder, depression, obesity, Parkinson's disease, a tic disorder, or an addictive disorder
08/12/2004US20040157869 (-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor
08/12/2004US20040157853 Thiazolopytimidines and their use as modulators of chemokine receptor activity
08/12/2004US20040157851 utility over a wide range of therapeutic applications, and may be used to treat a variety of disorders or illnesses, including stress-related disorders; depression, anxiety, stroke
08/12/2004US20040157850 Novel heterocyclic derivatives
08/12/2004US20040157844 6-azauracil derivatives as thyroid receptor ligands
08/12/2004US20040157829 useful in the treatment of central or peripheral nervous system disorders(e.g., migraine, ataxia, Parkinson's disease, bipolar disorders, epilepsy, hearing and vision loss, Alzheimer's disease, etc.) and as neuroprotective agent
08/12/2004US20040157827 2-Ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents
08/12/2004US20040157826 for example: the triethylammonium salt of 5,6-dihydro-6-oxo-N2-phenyl-5(sulfoxy)-4H-4,7-methanopyrazolo[3,4-e][1,3]diazepine-2,8(8H)-dicarboxamide
08/12/2004US20040157804 inhibition of HIV integrase
08/12/2004US20040157084 Containing imidazo-pyridine compound
08/12/2004US20040156869 Also 2-substituted quinolines, isoquinolines, pyridoquinolines, pyridoisoquinolines, and pyridoquinazolines; treatment of conditions responsive to capsaicin receptor modulation, especially various kinds of pain
08/12/2004US20040156791 Heating antipsychotic drug to vaporize; cooling to form condensation aerosol; kit for dispensing thin coating
08/12/2004US20040156790 Delivery of drug esters through an inhalation route
08/12/2004US20040156789 Delivery of antihistamines through an inhalation route